- Home
- CYCN vs LDWY Comparison
CYCN vs LDWY Comparison
Compare CYCN & LDWY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYCN
- LDWY
- Stock Information
- Founded
- CYCN 2018
- LDWY 1990
- Country
- CYCN United States
- LDWY United States
- Employees
- CYCN N/A
- LDWY N/A
- Industry
- CYCN Biotechnology: Pharmaceutical Preparations
- LDWY Advertising
- Sector
- CYCN Health Care
- LDWY Consumer Discretionary
- Exchange
- CYCN Nasdaq
- LDWY Nasdaq
- Market Cap
- CYCN 8.0M
- LDWY 9.2M
- IPO Year
- CYCN N/A
- LDWY 1991
- Fundamental
- Price
- CYCN $2.33
- LDWY $4.95
- Analyst Decision
- CYCN
- LDWY
- Analyst Count
- CYCN 0
- LDWY 0
- Target Price
- CYCN N/A
- LDWY N/A
- AVG Volume (30 Days)
- CYCN 24.8K
- LDWY 5.7K
- Earning Date
- CYCN 11-13-2025
- LDWY 08-28-2025
- Dividend Yield
- CYCN N/A
- LDWY N/A
- EPS Growth
- CYCN N/A
- LDWY N/A
- EPS
- CYCN N/A
- LDWY 1.66
- Revenue
- CYCN $2,174,000.00
- LDWY $71,244,000.00
- Revenue This Year
- CYCN N/A
- LDWY N/A
- Revenue Next Year
- CYCN N/A
- LDWY N/A
- P/E Ratio
- CYCN N/A
- LDWY $3.06
- Revenue Growth
- CYCN N/A
- LDWY 187.12
- 52 Week Low
- CYCN $1.27
- LDWY $3.02
- 52 Week High
- CYCN $9.47
- LDWY $6.19
- Technical
- Relative Strength Index (RSI)
- CYCN 45.15
- LDWY 41.34
- Support Level
- CYCN $2.13
- LDWY $4.64
- Resistance Level
- CYCN $2.59
- LDWY $5.35
- Average True Range (ATR)
- CYCN 0.21
- LDWY 0.33
- MACD
- CYCN 0.01
- LDWY -0.08
- Stochastic Oscillator
- CYCN 32.79
- LDWY 20.00
About CYCN Cyclerion Therapeutics Inc.
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop, and commercialize breakthrough treatments for serious and orphan diseases. Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators. Its pipeline products include Olinciguat, Praliciguat, and others.
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two industries: Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.